U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2024 - 2030

Research Methodology

A three-pronged approach was followed for deducing the U.S. home infusion therapy market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for U.S. home infusion therapy market to gather the most reliable and current information possible.

• We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
• We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
• We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
• We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
• We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of U.S. home infusion therapy market data depending on the type of information we’re trying to uncover in our research.

• Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

• Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

• Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

• Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

• Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

• Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

• This step also entails the finalization of the report scope and data representation pattern.

• Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

U.S. Home Infusion Therapy Market Categorization:

The U.S. home infusion therapy market was categorized into two segments, namely product (Infusion pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals).

Segment Market Methodology:

The U.S. home infusion therapy market was segmented into product, application. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

• Demand estimation of each product across countries/regions summed up to from the total market.

• Variable analysis for demand forecast.

• Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

• Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

• Used extensively for new product forecasting or analyzing penetration levels.

• Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

• Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

• This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The U.S. home infusion therapy market was analyzed at a regional level.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

U.S. home infusion therapy market companies & financials:

The U.S. home infusion therapy market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

• B. Braun Melsungen AG provides various healthcare products and services for emergency care, anesthesia, surgical procedures, extracorporeal blood treatment, and intensive care units. The company operates through four divisions: B. Braun Avitum, Hospital Care, Aesculap, and Outpatient Market. It has more than 260 subsidiaries and manufacturing sites in the U.S., Switzerland, Vietnam, Brazil, and Malaysia. In addition, B. Braun has operations in nearly 60 countries worldwide. It offers products and therapies for laparoscopic surgery, wound management, orthopedic joint replacement, infusion therapy, neurology, pain therapy, and nutrition therapy, among others. The company operates as a subsidiary of B. Braun Holding GmbH & Co. KG.

• Baxter manufactures and distributes pharmaceutical and medical devices for the treatment of kidney diseases, hemophilia, immune disorders, and other chronic & acute medical conditions. It also offers IV solutions products, which are used for drug delivery processes, and inhalation anesthetics for the treatment of irreversible kidney failure & end-stage renal diseases. The company operates through two segments: medical products and biosciences. In the biosciences segment, the company processes plasma-based proteins and recombinants for the treatment of bleeding disorders. Baxter operates in nearly 27 countries and markets its products in more than 100 countries worldwide.

• Caesarea Medical Electronics manufactures, develops, and designs high-performance multichannel ambulatory infusion pumps, syringe pumps, and enteral feeding devices. It also manufactures accessories such as bolus cables, wall chargers, carry bags, pulse oximeters, 9V battery packs, tabletop chargers, docking stations, extended & standard life batteries, lock boxes, and pole-mount chargers. The company’s products have applications in home care, hospitals, palliative care, anesthesia, and epidural administration, as well as Patient Controlled Analgesia (PCA). Its products are sold in nearly 60 countries across 6 continents.

• CareFusion Corporation develops and offers healthcare technologies including the LTV series of respiratory & ventilation products, Pyxis automated dispensing & patient identification systems, and Alaris IV sets & infusion pumps. The company specializes in the prevention of healthcare-associated infections and the reduction of medication errors. In March 2015, the company was acquired by BD.

• Fresenius Kabi AG deals in medicines and technologies for clinical nutrition, transfusion, and infusion. Its product line comprises clinical nutrition products, infusion therapies, and a comprehensive range of IV generic drugs, as well as medical devices for their administration. In addition, the company offers technologies for blood collection & storage, cell therapies, and transfusion medicines. As of 2017, the company had operations in more than 100 countries.

• ICU Medical, Inc. develops & markets pharmaceuticals & medical devices as well as technologies used in critical care applications, oncology, and vascular therapy. The company’s product line comprises innovative hemodynamic monitoring systems, needle-free closed blood sampling systems, advanced sensor catheters, closed-system hazardous drug handling devices & systems, custom infusion sets, and needle-free vascular access devices. The company specializes in Critical Care, nursing, medical devices, infection control, healthcare informatics, patient safety, IV Therapy, Closed System Transfer Devices, IV Workflow Software, IV Safety Software, IV Smart pumps, CSTDs, Needle-free IV Connectors, IV Solutions, IV Nutritionals, and Pharmaceuticals.

• JMS Co., Ltd. manufactures, distributes, and sells semisolid nutrition feeding devices for infusion & transfusion therapies, syringe pumps, infusion pumps, oral/enteral nutrition systems, extension tubes, safety venous indwelling catheters, safety scalp vein sets, disposable needles & syringes, infusion sets with needleless access port, and transfusion & infusion sets. In addition, it offers hemodialysis machines, central dialysate delivery systems, safety Arteriovenous (AV) fistula needles, hemodialysis blood tubing sets, hemodialysis kits, and dialysis solutions for CAPD.

• Smith’s Medical develops, manufactures, & supplies medical devices and specializes in providing equipment for hospital, home, emergency, & specialist settings. It also offers emergency healthcare solutions for homeland defense and medical-grade tubing products for industrial use. Moreover, the company offers veterinary devices, OEM services, medical device solutions for preclinical & clinical research, and monitoring & respiratory equipment. Smiths Medical offers products through its sales and distribution network in the U.S. as well as internationally. It operates as a subsidiary of Smiths Group Plc. The company’s manufacturing facilities are mainly located in the U.S., the UK, Mexico, and Italy.

• Terumo Corporation manufactures, distributes, and supplies medical devices & accessories worldwide. The company also offers endovascular therapy solutions, blood management systems, and hollow-fiber technology. Terumo Corporation’s Terumo Interventional Systems (TIS), is renowned for its leadership in embolization solutions, minimally invasive entry site management, and lesion access. The company has operations in more than 160 countries worldwide.

• Coram LLC offers infusion therapies & services to patients through a network of more than 90 locations, including over 70 infusion suites, in the U.S. The company provides infusion services about anti-infectives, nutrition, inotropes, Immunoglobulin (Ig), alpha-1, pre- & post-transplant, hemophilia, and pain & palliative care to all age groups. In addition, Coram LLC provides patient education, along with therapies, to patients and their family members.

Value chain-based sizing & forecasting

Supply Side Estimates

• Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

• Segment revenue determination via variable analysis and penetration modeling.

• Competitive benchmarking to identify market leaders and their collective revenue shares.

• Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

• Identifying parent markets and ancillary markets

• Segment penetration analysis to obtain pertinent

• revenue/volume

• Heuristic forecasting with the help of subject matter experts

• Forecasting via variable analysis

U.S. Home Infusion Therapy Market Report Objectives:

• Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

• Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

• Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

U.S. Home Infusion Therapy Market Report Assumptions:

• The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

• The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

• We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

• All market estimates and forecasts have been validated through primary interviews with the key industry participants.

• Inflation has not been accounted for to estimate and forecast the market.

• Numbers may not add up due to rounding off.

• Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

• Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

• Latin America includes Central American countries and the South American continent

• Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

• Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

• Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.